Lymphocyte-monocyte ratio (LMR) can predict bendamustine therapeutic efficacy in low-grade B-cell lymphoma.

Joji ShimonoKoh IzumiyamaShinichi ItoYutaka TsutsmiTakeshi KondoYasutaka KakinokiTakanori Teshima

Published in: International journal of laboratory hematology (2020)

Lymphocyte-monocyte ratio effectively predicts the efficacy of bendamustine therapy for low-grade B-cell lymphoma, particularly FL; its application may improve treatment strategies for this disease.

Keyphrases

low grade
peripheral blood
high grade
diffuse large b cell lymphoma
dendritic cells
endothelial cells
chronic lymphocytic leukemia